세계의 인슐린 펌프 시장 : 제품별, 최종 용도별, 예측(2024-2032년)

Global Insulin Pump Market is anticipated to record a CAGR of 12.4% from 2024 to 2032, driven by increasing prevalence of diabetes, technological advancements in insulin pump devices, and growing awareness about the benefits of continuous glucose monitoring (CGM) systems.

According to IDF, by 2045, projections indicate that 1 in 8 adults, or approximately 783 million people, will have diabetes, marking a 46% increase. With diabetes becoming a global epidemic, there is a growing demand for innovative solutions that offer better management and control of blood sugar levels. Insulin pumps offer patients greater flexibility, precision, and convenience in insulin delivery compared to traditional insulin injections, thus driving their adoption. Additionally, technological advancements such as integration with CGM systems, improved connectivity features, and the development of closed-loop systems are further fueling industry growth.

The overall insulin pump industry is classified based on product, accessories, end-use, and region.

Accessories segment is anticipated to grow substantially till 2032, owing to their role in enhancing the functionality and usability of insulin pump devices. Accessories such as infusion sets, reservoirs, and infusion site adhesives are essential components that ensure the efficient and reliable delivery of insulin. As the adoption of insulin pump therapy continues to rise, the demand for compatible accessories is also increasing. Moreover, manufacturers are focusing on developing accessories with advanced features such as extended wear time, improved comfort, and enhanced connectivity to meet the evolving needs of patients.

Hospitals & clinics from end-use segment is poised to grow rapidly during the forecast period, owing to their role in the adoption and utilization of insulin pump therapy. Hospitals often serve as distribution channels for insulin pump devices and accessories, providing patients with education, training, and ongoing clinical support. Moreover, with the growing prevalence of diabetes and the rising demand for advanced diabetes management solutions, further segment growth is anticipated.

Asia Pacific insulin pump market is set to gain traction till 2032, driven by increasing prevalence of diabetes, rapid urbanization, and improving healthcare infrastructure. Countries like China and India, with large diabetic populations, present significant opportunities for product adoption. Rising disposable incomes, increasing awareness about diabetes management, and government initiatives to improve healthcare access are further driving market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of diabetes
    • 3.2.1.2 Technological advancements in insulin pumps
    • 3.2.1.3 Favourable device insurance and reimbursement policies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of insulin pumps
    • 3.2.2.2 Stringent government regulations
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis
• 3.8 Reimbursement scenario
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates And Forecast, By Product, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Devices
  • 5.2.1 Tubed/tethered
  • 5.2.2 Tubeless
• 5.3 Accessories
  • 5.3.1 Battery
  • 5.3.2 Insulin reservoir or cartridges
  • 5.3.3 Insulin set insertion devices

Chapter 6 Market Estimates And Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Home care
• 6.3 Hospitals & clinics
• 6.4 Other end-users

Chapter 7 Market Estimates And Forecast, By Region, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Debiotech S.A.
• 8.2 F. Hoffmann La Roche AG
• 8.3 Insulet Corporation
• 8.4 Lenomed Medical
• 8.5 Medtronic plc
• 8.6 MicroPort Scientific Corporation
• 8.7 Nipro Corporation
• 8.8 Tandem Diabetic Care Inc.
• 8.9 Terumo Corporation
• 8.10 ViCentra B.V.
• 8.11 Ypsomed